血液凝固製品の世界市場レポート 2024

血液凝固製品の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.2%の年間複合成長率（CAGR）で21億6,000万米ドルに成長すると予想されます。予測期間の成長は、低侵襲手術の需要増加、世界的な外傷症例の増加、慢性疾患における止血アプリケーションの拡大、外来手術センターへのシフト、個別化医療とバイオマーカー研究への注力に起因すると考えられます。予測期間中に予想される主な動向には、止血の技術革新、止血技術の進歩、低侵襲処置への嗜好の高まり、慢性疾患の発生率の増加、生分解性止血剤への注目の高まりなどが含まれます。

予想される血液疾患の有病率の増加により、近い将来、血液凝固製品市場の成長が促進されると予想されます。血液障害または血液障害には、血液とその成分の組成、機能、挙動に影響を与えるさまざまな病状が含まれます。 血液凝固製品は、さまざまな血液疾患に関連する凝固および出血プロセスの管理において重要な役割を果たし、過剰な出血（出血）と過剰な凝固（血栓症）の両方に対処します。白血病財団の2021年6月の報告書によると、オーストラリアでは2021年に約11万人が血液疾患を抱えており、国内での血液がんや血液疾患の発生率の上昇により、その数は2035年までに27万5,000人を超えると予想されています。したがって、血液疾患の有病率の増加は、血液凝固製品市場の成長を促進する主要な推進力です。

心臓疾患の有病率の予想される増加は、血液凝固製品市場の成長に大きく貢献すると予想されます。心臓障害には、心臓と血管に影響を与える幅広いカテゴリーの病状が含まれます。 血液凝固製品は、心疾患に伴う出血の管理や、そのような症状の予防と治療において重要な役割を果たします。これらの製品は失血を最小限に抑えることで、輸血の必要性や心疾患に関連する潜在的な合併症を軽減します。 2023年 5月の疾病管理予防センター（CDC）によると、米国では心臓発作が40秒ごとに発生しており、毎年 80万5,000人のアメリカ人が心臓発作を経験しており、そのうち60万5,000人が初発作に直面しています。したがって、心疾患の有病率の増加は、血液凝固製品市場の成長を推進する重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の血液凝固製品市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 局所血液凝固製品
• 注入血液凝固製品
• 先進血液凝固製品
• 世界の血液凝固製品市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 外傷
• 手術
• 血友病
• 心筋梗塞
• その他の用途
• 世界の血液凝固製品市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界の血液凝固製品市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の血液凝固製品市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血液凝固製品市場の競合情勢
• 血液凝固製品市場の企業プロファイル
  • Pfizer Inc.
  • Abbott Laboratories
  • Thermo Fisher Scientific Inc.
  • Medtronic plc
  • Johnson And Johnson Pvt. Ltd.

第31章 その他の大手および革新的な企業

• Siemens Healthineers
• Becton Dickinson and Company（BD）
• Stryker Corporation
• Baxter International Inc.
• Boston Scientific Corporation
• F. Hoffmann-La Roche Ltd.
• BBraun Melsungen AG
• Fresenius Kabi AG
• Zimmer Biomet Holdings Inc.
• Olympus Corporation
• Grifols SA
• Terumo BCT Inc.
• Smith And Nephew plc
• Ethicon Suture Laboratories
• Hologic Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Hemostasis products are medical substances or devices employed to control bleeding and facilitate clotting (hemostasis) across diverse medical contexts. These products play a critical role in the management of bleeding disorders, promotion of wound healing, and ensuring the proper functioning of the body's clotting mechanisms.

The primary categories of hemostasis products include topical hemostasis products, infusible hemostasis products, and advanced hemostasis products. Topical hemostasis products encompass medical substances or materials specifically designed to halt or regulate bleeding. They find applications in various scenarios such as trauma, surgery, hemophilia, myocardial infarction, and others, with major end-users including hospitals, clinics, and others.

The hemostasis products market research report is one of a series of new reports from The Business Research Company that provides hemostasis products market statistics, including hemostasis products industry global market size, regional shares, competitors with a hemostasis products market share, detailed hemostasis products market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis products industry. This hemostasis products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostasis products market size has grown strongly in recent years. It will grow from $1.59 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The growth observed in the historical period can be attributed to an increase in surgical procedures, a growing aging population, a rise in the incidence of hemophilia, the expansion of healthcare infrastructure, and an increased awareness of blood clotting disorders.

The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.16 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to the increasing demand for minimally invasive surgeries, a global rise in trauma cases, the expansion of hemostasis applications in chronic diseases, a shift towards ambulatory surgical centers, and the focus on personalized medicine and biomarker research. Key trends expected in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, a growing preference for minimally invasive procedures, an increasing incidence of chronic diseases, and a heightened focus on biodegradable hemostatic agents.

The expected increase in the prevalence of blood disorders is poised to drive the growth of the hemostasis products market in the foreseeable future. Blood disorders, or hematologic disorders, encompass various medical conditions affecting the composition, function, and behavior of blood and its components. Hemostasis products play a crucial role in managing clotting and bleeding processes associated with different blood disorders, addressing both excessive bleeding (hemorrhage) and excessive clotting (thrombosis). According to the Leukemia Foundation's June 2021 report, approximately 110,000 people in Australia were living with blood disorders in 2021, a number expected to surpass 275,000 cases by 2035 due to the rising incidence of blood cancer and disorders in the country. Thus, the growing prevalence of blood disorders is a key driver fueling the growth of the hemostasis products market.

The anticipated rise in the prevalence of cardiac disorders is expected to contribute significantly to the growth of the hemostasis products market. Cardiac disorders encompass a broad category of medical conditions affecting the heart and blood vessels. Hemostasis products play a vital role in managing bleeding associated with cardiac disorders and in preventing and treating such conditions. By minimizing blood loss, these products reduce the need for blood transfusions and potential complications related to cardiac disorders. According to the Centers for Disease Control and Prevention (CDC) in May 2023, a heart attack occurs every 40 seconds in the United States, with 805,000 Americans experiencing a heart attack each year, 605,000 of whom are facing their first episode. Therefore, the increasing prevalence of cardiac disorders is a significant driver propelling the growth of the hemostasis products market.

The hemostasis products market is expected to encounter a notable challenge in the form of off-label product usage. This practice involves utilizing hemostatic products for purposes beyond their approved indications, potentially introducing risks and uncertainties in hemostatic treatment. Off-label marketing, as highlighted by the National Library of Medicine, undermines innovation by allowing manufacturers to expand product usage without the necessary research or safety testing. This practice may pose challenges to companies that diligently conduct research and development efforts. Consequently, off-label product usage poses a hindrance to the growth of the hemostasis products market.

Major companies in the hemostasis products market are focusing on the development of innovative drugs, including the Nexpowder endoscopic hemostasis system, and obtaining approvals for a comprehensive range of active and passive hemostatic products for bleeding control. The endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. Medtronic plc, a US-based medical device company, received clearance from the U.S. Food and Drug Administration in September 2022 for the Nexpowder Endoscopic Hemostasis System, designed for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and good tolerability.

In July 2021, Baxter International Inc., a US-based healthcare company, acquired assets such as the Polysaccharide Hemostatic System from CryoLife Inc. for $60.8 million. This strategic acquisition aims to expand Baxter's hemostasis product portfolio, gain access to PerClot's technology, and enhance its position in the hemostasis market. CryoLife Inc., a US-based medical device company, specializes in developing and manufacturing products for hemostasis.

Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic plc, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew plc, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

North America was the largest region in the hemostasis products market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemostasis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostasis products market consists of sales of hemostatic agents, hemostatic powders, hemostatic sponges, collagen, oxidized regenerated cellulose, gelatin, polysaccharide, flowable complex, thrombin complex, fibrin complex, synthetic sealants, and fresh frozen plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostasis Products Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostasis products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostasis products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hemostasis products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Product: Topical Hemostasis Product; Infusible Hemostasis Product; Advanced Hemostasis Product
• 2) By Application: Trauma; Surgery; Hemophilia; Myocardial Infarction; Other Applications
• 3) By End User: Hospitals; Clinics; Other End Users
• Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Medtronic plc; Johnson And Johnson Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostasis Products Market Characteristics

3. Hemostasis Products Market Trends And Strategies

4. Hemostasis Products Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Hemostasis Products Market Size and Growth

• 5.1. Global Hemostasis Products Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Hemostasis Products Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Hemostasis Products Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hemostasis Products Market Segmentation

• 6.1. Global Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Topical Hemostasis Product
• Infusible Hemostasis Product
• Advanced Hemostasis Product
• 6.2. Global Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Trauma
• Surgery
• Hemophilia
• Myocardial Infarction
• Other Applications
• 6.3. Global Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Other End Users

7. Hemostasis Products Market Regional And Country Analysis

• 7.1. Global Hemostasis Products Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Hemostasis Products Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hemostasis Products Market

• 8.1. Asia-Pacific Hemostasis Products Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hemostasis Products Market

• 9.1. China Hemostasis Products Market Overview
• 9.2. China Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hemostasis Products Market

• 10.1. India Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hemostasis Products Market

• 11.1. Japan Hemostasis Products Market Overview
• 11.2. Japan Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hemostasis Products Market

• 12.1. Australia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hemostasis Products Market

• 13.1. Indonesia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hemostasis Products Market

• 14.1. South Korea Hemostasis Products Market Overview
• 14.2. South Korea Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hemostasis Products Market

• 15.1. Western Europe Hemostasis Products Market Overview
• 15.2. Western Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hemostasis Products Market

• 16.1. UK Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hemostasis Products Market

• 17.1. Germany Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hemostasis Products Market

• 18.5. France Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.6. France Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.7. France Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hemostasis Products Market

• 19.9. Italy Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.10. Italy Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.11. Italy Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hemostasis Products Market

• 20.13. Spain Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.14. Spain Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.15. Spain Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hemostasis Products Market

• 21.1. Eastern Europe Hemostasis Products Market Overview
• 21.2. Eastern Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hemostasis Products Market

• 22.1. Russia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hemostasis Products Market

• 23.1. North America Hemostasis Products Market Overview
• 23.2. North America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hemostasis Products Market

• 24.1. USA Hemostasis Products Market Overview
• 24.2. USA Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hemostasis Products Market

• 25.1. Canada Hemostasis Products Market Overview
• 25.2. Canada Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hemostasis Products Market

• 26.1. South America Hemostasis Products Market Overview
• 26.2. South America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hemostasis Products Market

• 27.1. Brazil Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hemostasis Products Market

• 28.1. Middle East Hemostasis Products Market Overview
• 28.2. Middle East Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hemostasis Products Market

• 29.1. Africa Hemostasis Products Market Overview
• 29.2. Africa Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hemostasis Products Market Competitive Landscape And Company Profiles

• 30.1. Hemostasis Products Market Competitive Landscape
• 30.2. Hemostasis Products Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Abbott Laboratories
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Medtronic plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Johnson And Johnson Pvt. Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Hemostasis Products Market Other Major And Innovative Companies

• 31.1. Siemens Healthineers
• 31.2. Becton Dickinson and Company (BD)
• 31.3. Stryker Corporation
• 31.4. Baxter International Inc.
• 31.5. Boston Scientific Corporation
• 31.6. F. Hoffmann-La Roche Ltd.
• 31.7. BBraun Melsungen AG
• 31.8. Fresenius Kabi AG
• 31.9. Zimmer Biomet Holdings Inc.
• 31.10. Olympus Corporation
• 31.11. Grifols S.A.
• 31.12. Terumo BCT Inc.
• 31.13. Smith And Nephew plc
• 31.14. Ethicon Suture Laboratories
• 31.15. Hologic Inc.

32. Global Hemostasis Products Market Competitive Benchmarking

33. Global Hemostasis Products Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Hemostasis Products Market

35. Hemostasis Products Market Future Outlook and Potential Analysis

• 35.1 Hemostasis Products Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Hemostasis Products Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Hemostasis Products Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer